Abbas T. Monfared
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Travel barriers to amyloid-targeting infusion access among older adults.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: March 13, 2026
Identification and characterization of intracerebral hemorrhage events in elderly veterans with alzheimer's disease in the veterans affairs healthcare system.
Journal: Scientific reports
Published: March 02, 2026
American's overall and equity-based societal valuation of a disease-modifying Alzheimer's treatment: Results from a discrete choice experiment.
Journal: The journal of prevention of Alzheimer's disease
Published: February 27, 2025
Prevalence of Mild Cognitive Impairment and Alzheimer's Disease Identified in Veterans in the United States.
Journal: Journal of Alzheimer's disease : JAD
Published: May 24, 2024
Rule-Based Identification of Individuals with Mild Cognitive Impairment or Alzheimer's Disease Using Clinical Notes from the United States Veterans Affairs Healthcare System.
Journal: Neurology and therapy
Published: June 14, 2023
Assessing out-of-pocket expenses and indirect costs for the Alzheimer disease continuum in the United States.
Journal: Journal of managed care & specialty pharmacy
Published: June 12, 2023
Therapeutic preference for Alzheimer's disease treatments: a discrete choice experiment with caregivers and neurologists.
Journal: Alzheimer's research & therapy
Published: August 09, 2022
The epidemiology of mild cognitive impairment, Alzheimer's disease and related dementia in U.S. veterans.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 04, 2022
Comparative efficacy of lemborexant and other insomnia treatments: a network meta-analysis.
Journal: Journal of managed care & specialty pharmacy
Published: June 14, 2021
Real-world systemic therapy treatment patterns for squamous cell carcinoma of the head and neck in Canada.
Journal: Current oncology (Toronto, Ont.)
Published: May 03, 2019
Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada.
Journal: PharmacoEconomics - open
Published: January 09, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026